VšĮ "European Life Science and Knowledge Institute" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 206,868 |
| 28,165 |
| 0 |
| - |
| - |
| - |
| - |
| -3,657 |
| 56,090 |
| 5,674 |
| 46,759 |
| -0.05 |
| -15.34 |
| - |
| - |
| - |
| - |
| 2024 |
|---|
| 263,421 |
| 37,197 |
| 0 |
| - |
| - |
| - |
| - |
| 23 |
| 25,345 |
| 3,171 |
| 22,197 |
| -0.01 |
| 1,101.96 |
| - |
| - |
| - |
| - |
| 2025 |
|---|
| 215,252 |
| 47,616 |
| 0 |
| - |
| - |
| - |
| - |
| 12,468 |
| 71,129 |
| 1,502 |
| 82,095 |
| 0.05 |
| 5.70 |
| - |
| - |
| - |
| - |
| 2025 |
|---|
| 215,252 |
| 47,616 |
| 0 |
| - |
| - |
| - |
| - |
| 12,468 |
| 71,129 |
| 1,502 |
| 82,095 |
| 0.05 |
| 5.70 |
| - |
| - |
| - |
| - |
Turnover (€)
2025
Turnover (€)
215,252 €-18 % *
Sales per employee (€)
47,616 €28 % *
Profit before tax (€)
0 €- *
Net Profit (€)
-Profit per employee (€)
-Total profitability (%)
-Net profitability (%)
-Equity (€)
12,468 €54,109 % *
Amounts Payable And Liabilities (€)
71,129 €181 % *
Non-current Assets (€)
1,502 €-53 % *
CurrentAssets (€)
82,095 €270 % *
Working capital requirement
0.05 600.00 % *
Debt-to-equity ratio
5.70 -99.48 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-EBIT (€)
-